Page last updated: 2024-08-05 11:07:00

anthracenes

Compounds containing an anthracene skeleton.

ChEBI ID: 46955

Members (23)

MemberDefinitionRole
1-(9-anthracenylmethyl)-3-piperidinol1-(9-anthracenylmethyl)-3-piperidinol
1-Anilino-9,10-dioxo-2-anthroic acid1-Anilino-9,10-dioxo-2-anthroic acid
10,10-bis((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone10,10-bis[(2-fluoro-4-pyridinyl)methyl]-9-anthracenone
9-nitroanthracene9-Nitroanthracene
9,10-bis(phenylethynyl)anthracene9,10-bis(phenylethynyl)anthracene
9,10-diphenylanthraceneA member of the class of anthracenes that is anthracene in which both of the hydrogens on the central ring are substituted by phenyl groups.9,10-diphenylanthracene
alloinA C-glycosyl compound that is beta-D-glucopyranose in which the anomeric hydroxy group is replaced by a 4,5-dihydroxy-2-(hydroxymethyl)-10-oxo-9,10-dihydroanthracen-9-yl moiety (the 9S diastereoisomer).aloin A
aloe emodin anthroneAloe emodin anthrone
anthraceneAn ortho-fused tricyclic hydrocarbon comprising three fused benzene rings.anthracene
anthralinAn anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.anthralin
benzoctaminebenzoctamine
bisantreneA hydrazone resulting from the formal condensation of both of the aldehyde groups of anthracene-9,10-dicarbaldehyde with 2-hydrazinyl-4,5-dihydro-1H-imidazole.bisantrene
brd 7389LSM-4550
cp-640186(3R)-1'-(9-anthrylcarbonyl)-3-(morpholin-4-ylcarbonyl)-1,4'-bipiperidine
desmethylmaprotilinedemethylmaprotiline
isobarbaloinA C-glycosyl compound that is beta-D-glucopyranose in which the anomeric hydroxy group is replaced by a 4,5-dihydroxy-2-(hydroxymethyl)-10-oxo-9,10-dihydroanthracen-9-yl moiety (the 9R diastereoisomer).aloin B
LSM-34582LSM-34582
maprotilineMaprotiline
maprotiline hydrochlorideMaprotiline hydrochloride
rhein-9-anthroneRheinanthrone
trausabunmelitracen
triptyceneTriptycene
xe 991, anthracenoneXE991

Research

Studies (3,231)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19901,309 (40.51)18.7374
1990's488 (15.10)18.2507
2000's557 (17.24)29.6817
2010's716 (22.16)24.3611
2020's161 (4.98)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials380 (10.78%)5.53%
Reviews164 (4.65%)6.00%
Case Studies168 (4.76%)4.05%
Observational2 (0.06%)0.25%
Other2,812 (79.75%)84.16%